Background/Aims: Oxidative stress results in protein oxidation and is implicated in carcinogenesis. Sulfiredoxin (Srx) is responsible for the enzymatic reversal of inactivated peroxiredoxin (Prx). Nuclear factor E2-related factor 2 (Nrf2) binds to antioxidant responsive elements and upregulates the expression of Srx and Prx during oxidative stress. We aimed to elucidate the biological functions and potential roles of Srx in lung cancer. Methods: To study the roles of Srx and Prx III in lung cancer, we compared the protein levels of Nrf2, Prxs, thioredoxin, and Srx in 40 surgically resected human lung cancer tissues using immunoblot and immunohistochemical analyses. Transforming growth factor-β 1 , tumor necrosis factor-α, and camptothecin treatment were used to examine Prx III inactivation in Mv1Lu mink lung epithelial cells and A549 lung cancer cells. Results: Prx I and Prx III proteins were markedly overexpressed in lung cancer tissues. A significant increase in the oxidized form of a cysteine sulfhydryl at the catalytic site of Prxs was found in carcinogenic lung tissue compared to normal lung tissue. Densitometric analyses of immunoblot data revealed significant Srx expression, which was higher in squamous cell carcinoma tissue (60%, 12/20) than in adenocarcinoma (20%, 4/20). Also, Nrf2 was present in the nuclear compartment of cancer cells. Conclusions: Srx and Prx III proteins were markedly overexpressed in human squamous cell carcinoma, suggesting that these proteins may play a protective role against oxidative injury and compensate for the high rate of mitochondrial metabolism in lung cancer.
INTRODUCTION
Oxidative stress and growth factor stimulation can cause harmful changes in DNA, proteins, and lipids. Signaling by reactive oxygen species (ROS), especially hydrogen peroxide, plays a central role in a variety of cellular events such as growth, proliferation, and carcinogenesis [1] . The lungs are constantly exposed to oxidative stress and xenobiotic challenges such as environmental pollution, toxic fumes, and cigarette smoke during gas exchange, and many specialized and dedicated proteins function as antioxidants to protect pulmonary epithelial cells from the heavy oxidative stress load. These antioxidant-related proteins include glutathione, catalase, superoxide dismutase, manganese superoxide dismutase, nicotinamide adenine dinucleotide phosphate oxidases, peroxiredoxins (Prxs), and others [2] .
Prxs are a ubiquitous family of peroxidases that function to protect human cells from oxidative stress. Involved in a number of cellular activities, Prxs remove hydrogen peroxide produced during normal cellular metabolism, growth, differentiation, inflammation, and proliferation [3, 4] .
Sulfiredoxins (Srxs) are a family of low molecular weight, sulfur-containing proteins that function to maintain cellular redox balance. Srx is responsible for enzymatically reversing inactivated Prxs, in an ATP-,
Mg
2+ -, and Ca 2+ -dependent manner [5] [6] [7] .
Nuclear factor E2-related factor 2 (Nrf2) is a well-known master transcription factor for antioxidant responsive element (ARE)-mediated protein expression [8, 9] . The pathway involving Kelch-like ECH-associated protein 1 (Keap1), Nrf2, and ARE-mediated protein expression is critical for protecting cells from both endogenous and exogenous stress [10, 11] . A recent study using Nrf2-knockout mice clearly demonstrated that hyperoxiainduced expression of Srx in the lungs is dependent on the Nrf2-signaling pathway [12] .
During carcinogenesis, cancer cells take advantage of the Nrf2/ARE protective machinery to survive the oxidative stress triggered by uncontrolled growth, chemotherapy, and radiotherapy, allowing them to endure the toxic effects of the therapy [13] [14] [15] [16] . It was recently reported that a cigarette smoke induced-Keap1 mutation caused the release of Nrf2 and the activation of AREmediated protein transcription, contributing to the development of squamous carcinoma in the head and neck [17, 18] . However, the pathophysiological role of Nrf2 and its associations among the Prx and Srx proteins in human lung disease have not been clearly defined.
Our aim was to elucidate the role of ROS-related signal transduction and to explore the associations between Nrf2, peroxiredoxin, sulfiredoxin, and thioredoxin (Trx) in human lung cancer. Thus, we examined Nrf2-dependent, ARE-mediated expression of Srx in human lung cancer. 
METHODS

Materials
Immunocytochemistry
Cells were grown on glass-bottom culture dishes, fixed 
Co-immunoprecipitation and immunoblot analysis
For immunoblot analysis, lung tissues were homogenized in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Triton X, and a protease inhibitor cocktail (Sigma-Aldrich). Cell lysates were centrifuged at 12,000 rpm for 10 minutes at 4°C, and the samples were boiled for 5 minutes in 2 × sample buffer. Immunoreactivity was visualized with diaminobenzidine.
The sections were counterstained with hematoxylin and eosin.
Statistical analysis
Data were analyzed at least three times using SPSS 
RESULTS
Localization of Prx III and Srx in A549 cells
Immunocytochemical analysis followed by confocal microscopy demonstrated the subcellular localization of Prx III and Srx in A549 cells. Prx III co-localized specifically with the Mitotracker dye in the mitochondrial fraction (Fig. 1A) . Srx was present in the cytosol under basal conditions (Fig. 1B) . The localization of Srx and Prx III was also examined by immunoblot analysis of the soluble cytosolic and heavy membrane fractions. Srx was found predominantly in the cytosol, and Prx III was detected in the mitochondrial fraction (Fig. 1) .
Oxidation of Prx III in mink lung epithelial cells
Mink lung epithelial cells (Mv1Lu) were exposed to TGF-β1 (2 ng/mL) for 72 hours, after which only the oxidized form of Prx III was identified by two-dimensional (2D) electrophoresis and immunoblot analysis (Fig. 2) .
Srx-dependent regulation of Prx III oxidation in A549 cells
The amount of Srx was reduced by 90% in A549 cells transfected with Srx-specific siRNA (20 nM) compared to control cells (Fig. 3A) . A549 cells were treated with TGF-β1 (10 ng/mL) for 72 hours, and the cell lysates were subjected to 2D electrophoresis followed by immunoblot analysis. The sulfinic forms of Prx III were found only in A549 cells depleted of Srx, and oxidized Prx III was observed in A549 cells treated with either TNF-α (10 ng/ mL) or camptothecin (10 μM) for 24 hours (Fig. 4) .
Nrf2-dependent, ARE-mediated expression of proteins in human lung cancer
The expression levels of Nrf2, Prx, Trx, and Srx were examined by concomitant immunoblot analysis. The expression levels of Nrf2, Prxs (particularly Prx I and III), Trx, and Srx were higher in lung cancer tissues than in the paired normal lung tissues (Fig. 5 ). Significant Nrf2 overexpression was observed in the nucleic fraction of lung cancer tissues.
Srx overexpression in human lung cancer
We examined Srx expression in 40 resected stage I and II lung cancers using immunoblot analysis. Markedly increased Srx expression was observed in 60% of squamous cell carcinomas compared to the paired normal ) and sulfiredoxin (Srx) in both lung cancer (C) and paired normal tissue (N) was subjected to immunoblot analysis with antibodies to each, respectively. Expression of nuclear factor E2-related factor 2 (Nrf2) in both lung cancer (C) and paired normal tissue (N) were subjected to subcellular fractionation and the nucleic fraction (NR) was subjected to immunoblot analysis with Nrf2 antibody. were transfected with either a control siRNA or a siRNA specific for human Srx mRNA, after which cell lysates were prepared and subjected to immunoblot analysis with antibodies to Srx or α-tubulin (A). Two days after cells were transfected as in (A), cells were exposed to 10 ng/mL TGF-β1 for 3 days and cell lysates were analyzed with 2D gel electrophoresis, followed by immunoblot analysis with Prx III antibody (B). Ox, oxidation form; Re, reduced form. Fig. 6B ). Srx expression levels in lung cancer and paired normal tissues were quantitated by densitometry (Fig. 7A and 8A ), revealing that Srx was significantly overexpressed in both squamous cell carcinoma and adenocarcinoma cell types ( Fig. 7B and  8B ). Srx protein was markedly overexpressed in all lung A b Figure 9 . Expression of sulfiredoxin (Srx) and survival in all cell types of lung cancer tissue. Data are expressed as relative to the corresponding value for expression of Srx in all lung cancer cell types and paired normal tissue (A). Data are expressed as relative to the corresponding value for expression and survival of Srx in all cell types of lung cancer and paired normal tissue (B).
A b
cancer subtypes (p < 0.001; Fig. 9A ).
Srx expression and survival in lung cancer
Srx expression level negatively correlated with patient survival but was not significant (Fig. 9B) .
Srx expression in lung cancer tissues
Immunohistochemical staining of paraffin-embedded tissues using an anti-Srx monoclonal antibody demonstrated that the increase in Srx protein originated from cancer tissue; the tumor tissue was much more heavily stained than the normal lung parenchyma. Srx protein was located mainly in the cytoplasm of cancer cells, but was also found in the nuclei and nucleoli (Fig. 10) .
DISCUSSION
The principal finding of this study is that Srx protein was markedly overexpressed in human lung squamous cell carcinoma. This suggests that Srx, in cooperation with increased levels of Prxs (particularly Prx I and III) and Trx, may protect pulmonary epithelial cells from oxidative injury. Furthermore, a significantly increased level of Nrf2 was found in the nucleic fraction of lung cancer tissues, where it may regulate ARE-mediated protein expression.
It was reported previously that Prxs are expressed abundantly in bronchial and spulmonary epithelial cells [19] . However, the connection between these elevated protein levels and underlying overexpression mechanisms was not clear. Our present study showed that the expression levels of Nrf2, Prxs (particularly Prx I and III), Trx, and Srx were higher in cancer tissues than in paired normal lung tissues. Furthermore, Nrf2 was present at the site where Srx was overexpressed in lung cancer tissues. A previous study revealed that increased expression of Srx, which regenerates inactive 2-Cys Prx, relies on the Nrf2-dependent signaling pathway [17, [20] [21] [22] [23] [24] [25] . Therefore, we In conclusion, the Srx and Prx III proteins were markedly overexpressed in a Nrf2-dependent manner in human squamous cell carcinoma, suggesting that these proteins may play a protective role against oxidative injury and compensate for the high rate of mitochondrial metabolism in lung cancer cells.
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